Top

Published in:

01-10-2011 | Advances in Nonnuclear Imaging Technologies

Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging

Authors: Manish Motwani, BSc, MB ChB, Timothy Lockie, BSc, MB ChB, John P. Greenwood, MB ChB, PhD, Sven Plein, MD, PhD

Published in: Journal of Nuclear Cardiology | Issue 5/2011

Excerpt

Cardiovascular magnetic resonance (CMR) has emerged as a highly versatile non-invasive imaging modality that provides high-resolution images of the heart in any desired plane. In patients with coronary artery disease (CAD), CMR can provide information on myocardial anatomy, function, ischemia, viability, and coronary artery anatomy all within a single study and without the use of ionizing radiation (Figure 1). …

Hachamovitch R, Hayes S, Friedman JD, Cohen I, Shaw LJ, Germano G, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: What is the warranty period of a normal scan? J Am Coll Cardiol 2003;41:1329-40.PubMedCrossRef

Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003;42:1318-33.PubMedCrossRef

Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993;22:665-70.PubMedCrossRef

Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.PubMed

Shaw LJ, Berman DS, Maron DJ, Mancini GBJ, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91.PubMedCrossRef

Schwitter J, Wacker CM, van Rossum AC, Lombardi M, Al-Saadi N, Ahlstrom H, et al. MR-IMPACT: Comparison of perfusion-cardiac magnetic resonance with single-photon emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J 2008;29:480-9.PubMedCrossRef

Wolff SD, Schwitter J, Coulden R, Friedrich MG, Bluemke DA, Biederman RW, et al. Myocardial first-pass perfusion magnetic resonance imaging: A multicenter dose-ranging study. Circulation 2004;110:732-7.PubMedCrossRef

Keijer JT, van Rossum AC, Wilke N, van Eenige MJ, Jerosch-Herold M, Bronzwaer JG, et al. Magnetic resonance imaging of myocardial perfusion in single-vessel coronary artery disease: Implications for transmural assessment of myocardial perfusion. J Cardiovasc Magn Reson 2000;2:189-200.PubMedCrossRef

Keijer JT, van Rossum AC, van Eenige MJ, Bax JJ, Visser FC, Teule JJ, et al. Magnetic resonance imaging of regional myocardial perfusion in patients with single-vessel coronary artery disease: Quantitative comparison with (201)Thallium-SPECT and coronary angiography. J Magn Reson Imaging 2000;11:607-15.PubMedCrossRef

10.

Sakuma H, Suzawa N, Ichikawa Y, Makino K, Hirano T, Kitagawa K, et al. Diagnostic accuracy of stress first-pass contrast-enhanced myocardial perfusion MRI compared with stress myocardial perfusion scintigraphy. AJR Am J Roentgenol 2005;185:95-102.PubMed

11.

Greenwood JP, Maredia N, Younger JF, Brown JM, Nixon J, Everett CC, et al. Clinical evaluation of magnetic resonance imaging in coronary heart disease (The CE-MARC Study): A prospective evaluation of 750 patients (Abstract). Circulation 2010;122:A21797.

12.

Jahnke C, Nagel E, Gebker R, Kokocinski T, Kelle S, Manka R, et al. Prognostic value of cardiac magnetic resonance stress tests: Adenosine stress perfusion and dobutamine stress wall motion imaging. Circulation 2007;115:1769-76.PubMedCrossRef

13.

Atkinson DJ, Burstein D, Edelman RR. First-pass cardiac perfusion: Evaluation with ultrafast MR imaging. Radiology 1990;174:757-62.PubMed

14.

Kellman P, Arai AE. Imaging sequences for first pass perfusion—A review. J Cardiovasc Magn Reson 2007;9:525-37.PubMedCrossRef

15.

Gebker R, Schwitter J, Fleck E, Nagel E. How we perform myocardial perfusion with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2007;9:539-47.PubMedCrossRef

16.

Gerber BL. MR perfusion imaging. What will be its impact for detection of coronary disease in the future? Eur Heart J 2008;29:434-5.PubMedCrossRef

17.

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.PubMedCrossRef

18.

Panting JR, Gatehouse PD, Yang GZ, Grothues F, Firmin DN, Collins P, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 2002;346:1948-53.PubMedCrossRef

19.

Plein S, Greenwood JP, Ridgway JP, Cranny G, Ball SG, Sivananthan MU. Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol 2004;44:2173-81.PubMedCrossRef

20.

Bodi V, Sanchis J, Lopez-Lereu MP, Losada A, Nunez J, Pellicer M, et al. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol 2005;46:1747-52.PubMedCrossRef

21.

Kozerke S, Plein S. Accelerated CMR using zonal, parallel and prior knowledge driven imaging methods. J Cardiovasc Magn Reson 2008;10:29.PubMedCrossRef

22.

Tsao J, Boesiger P, Pruessmann KP. k-t BLAST and k-t SENSE: Dynamic MRI with high frame rate exploiting spatiotemporal correlations. Magn Reson Med 2003;50:1031-42.PubMedCrossRef

23.

Ge L, Kino A, Griswold M, Mistretta C, Carr JC, Li D. Myocardial perfusion MRI with sliding-window conjugate-gradient HYPR. Magn Reson Med 2009;62:835-9.PubMedCrossRef

24.

Plein S, Ryf S, Schwitter J, Radjenovic A, Boesiger P, Kozerke S. Dynamic contrast-enhanced myocardial perfusion MRI accelerated with k-t sense. Magn Reson Med 2007;58:777-85.PubMedCrossRef

25.

Maredia N, Radjenovic A, Kozerke S, Larghat A, Greenwood JP, Plein S. Effect of improving spatial or temporal resolution on image quality and quantitative perfusion assessment with k-t SENSE acceleration in first-pass CMR myocardial perfusion imaging. Magn Reson Med 2010;64:1616-24.PubMedCrossRef

26.

Di Bella EVR, Parker DL, Sinusas AJ. On the dark rim artifact in dynamic contrast-enhanced MRI myocardial perfusion studies. Magn Reson Med 2005;54:1295-9.PubMedCrossRef

27.

Plein S, Kozerke S, Suerder D, Luescher TF, Greenwood JP, Boesiger P, et al. High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J 2008;29:2148-55.PubMedCrossRef

28.

Plein S, Schwitter J, Suerder D, Greenwood JP, Boesiger P, Kozerke S. k-Space and time sensitivity encoding—Accelerated myocardial perfusion MR imaging at 3.0 T: Comparison with 1.5 T1. Radiology 2008;249:493-500.PubMedCrossRef

29.

Manka R, Vitanis V, Boesiger P, Flammer AJ, Plein S, Kozerke S. Clinical feasibility of accelerated, high spatial resolution myocardial perfusion imaging. JACC Cardiovasc Imaging 2010;3:710-7.PubMedCrossRef

30.

Cheng ASH, Pegg TJ, Karamitsos TD, Searle N, Jerosch-Herold M, Choudhury RP, et al. Cardiovascular magnetic resonance perfusion imaging at 3-tesla for the detection of coronary artery disease: A comparison with 1.5-tesla. J Am Coll Cardiol 2007;49:2440-9.PubMedCrossRef

31.

Bartunek J, Sys SU, Heyndrickx GR, Pijls NHJ, De Bruyne B. Quantitative coronary angiography in predicting functional significance of stenoses in an unselected patient cohort. J Am Coll Cardiol 1995;26:328-34.PubMedCrossRef

32.

Pijls NH, Fearon WF, Tonino PA, Siebert U, Ikeno F, Bornschein B, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol 2010;56:177-84.PubMedCrossRef

33.

Pijls NH, van Schaardenburgh P, Manoharan G, Boersma E, Bech JW, van’t Veer M, et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER study. J Am Coll Cardiol 2007;49:2105-11.PubMedCrossRef

34.

Pijls NH, de Bruyne B, Peels K, van der Voort PH, Bonnier HJ, Bartunek J, et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 1996;334:1703-9.PubMedCrossRef

35.

Lockie T, Ishida M, Perera D, Chiribiri A, De Silva K, Kozerke S, et al. High-resolution magnetic resonance myocardial perfusion imaging at 3.0-Tesla to detect hemodynamically significant coronary stenoses as determined by fractional flow reserve. J Am Coll Cardiol 2010;57:70-5.CrossRef

36.

Tonino PA, Fearon WF, De Bruyne B, Oldroyd KG, Leesar MA, Ver Lee PN, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study: Fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol 2010;55:2816-21.PubMedCrossRef

37.

King’s College London. MR INFORM—MR perfusion imaging to guide management of patients with stable coronary artery disease. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available from: http://clinicaltrials.gov/ct2/show/NCT01236807.

38.

Bache RJ, Schwartz JS. Effect of perfusion pressure distal to a coronary stenosis on transmural myocardial blood flow. Circulation 1982;65:928-35.PubMedCrossRef

39.

Stanton T, Marwick TH. Assessment of subendocardial structure and function. JACC Cardiovasc Imaging 2010;3:867-75.PubMedCrossRef

40.

Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983;1:994-1001.PubMedCrossRef

41.

Manka R, Jahnke C, Kozerke S, Vitanis V, Crelier G, Gebker R, et al. Dynamic 3-dimensional stress cardiac magnetic resonance perfusion imaging: Detection of coronary artery disease and volumetry of myocardial hypoenhancement before and after coronary stenting. J Am Coll Cardiol 2011;57:437-44.PubMedCrossRef

42.

Shin T, Hu HH, Pohost GM, Nayak KS. Three dimensional first-pass myocardial perfusion imaging at 3T: Feasibility study. J Cardiovasc Magn Reson 2008;10:57.PubMedCrossRef

Title: Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging
Authors: Manish Motwani, BSc, MB ChB
Timothy Lockie, BSc, MB ChB
John P. Greenwood, MB ChB, PhD
Sven Plein, MD, PhD
Publication date: 01-10-2011
Publisher: Springer-Verlag
Published in: Journal of Nuclear Cardiology / Issue 5/2011
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI: https://doi.org/10.1007/s12350-011-9434-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2011

A selection of recent original research papers

Ischemic electrocardiogram during pharmacologic stress with regadenoson

Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events

CME instructions: The nuclear cardiology report: Problems, predictors, and improvement. A report from the ICANL database

Excellence in imaging—ASNC’s strategic pathway

ASNC Model Coverage Policy: Single photon myocardial perfusion imaging

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page